The following definitions apply to this chapter: (a) âAlternate method of oocyte retrievalâ means a method of oocyte retrieval that does not involve the pharmaceutically induced manipulation of oocyte production. (b) âAssisted oocyte productionâ or âAOPâ means surgical extraction of oocytes following pharmaceutically induced manipulation of oocyte production through the use of ovarian stimulation. (c) âInformed consentâ means a research participant understands the material facts reasonably necessary to make a determination to participate or to refuse from participating in the medical research without the intervention of any element of force, fraud, deceit, duress, coercion, or undue influence on the research participantâs decision. (d) âInstitutional review boardâ means a body established in accordance with federal regulations, including Part 46 (commencing with Section 46.101) of Subchapter A of Subtitle A of Title 45 of the Code of Federal Regulations. (e) âOocyteâ means a female egg or egg cell of a human female. (f) âResearch participantâ means any person undergoing AOP or any alternative method of ovarian retrieval for research or for the development of medical therapies, including those who would not meet the definition of âsubjectâ under 45 C.F.R. 46.102. The protections afforded to human subjects under an institutional review board apply to research participants in this chapter.
‹ Prev All California sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.